ENTA Enanta Pharmaceuticals, Inc.

NASDAQ
$8.69

Enanta Pharmaceuticals, Inc. (ENTA) SEC Filings

Everything ENTA has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

60 filings
Date Form Filing
10-K
SCHEDULE 13G
8-K Earnings Release · Executive Change · Other Reg Fd · Restructuring
SCHEDULE 13G/A
8-K Other · Other Event
8-K Executive Change · Reg Fd
10-Q
4
10-Q
4
4
4
4
4
4
4
4
4
4
4
4
10-Q
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.